Pangenomic analysis of Chinese gastric cancer

Yingyan Yu,Zhen Zhang,Xiaorui Dong,Ruixin Yang,Zhongqu Duan,Zhen Xiang,Jun Li,Guichao Li,Fazhe Yan,Hongzhang Xue,Du Jiao,Jinyuan Lu,Huimin Lu,Wenmin Zhang,Yangzhen Wei,Shiyu Fan,Jing Li,Jingya Jia,Jun Zhang,Jun Ji,Pixu Liu,Hui Lu,Hongyu Zhao,Saijuan Chen,Chaochun Wei,Hongzhuan Chen,Zhenggang Zhu
DOI: https://doi.org/10.1038/s41467-022-33073-7
IF: 16.6
2022-09-15
Nature Communications
Abstract:Abstract Pangenomic study might improve the completeness of human reference genome (GRCh38) and promote precision medicine. Here, we use an automated pipeline of human pangenomic analysis to build gastric cancer pan-genome for 185 paired deep sequencing data (370 samples), and characterize the gene presence-absence variations (PAVs) at whole genome level. Genes ACOT1 , GSTM1, SIGLEC14 and UGT2B17 are identified as highly absent genes in gastric cancer population. A set of genes from unaligned sequences with GRCh38 are predicted. We successfully locate one of predicted genes GC0643 on chromosome 9q34.2. Overexpression of GC0643 significantly inhibits cell growth, cell migration and invasion, cell cycle progression, and induces cell apoptosis in cancer cells. The tumor suppressor functions can be reversed by sh GC0643 knockdown. The GC0643 is approved by NCBI database (GenBank: MW194843.1). Collectively, the robust pan-genome strategy provides a deeper understanding of the gene PAVs in the human cancer genome.
multidisciplinary sciences
What problem does this paper attempt to address?